Skip to main content
. 2020 Mar 25;10(3):e034202. doi: 10.1136/bmjopen-2019-034202

Table 1.

Demographic characteristics of patients with prostate cancer stratified by the previous use or non-use of ADT (n=10 893)

Characteristic Patients not receiving ADT (n=3631) Patients receiving ADT (n=7262) P value
Total no Column % Total no Column %
Age (years), mean (SD) 74.26 (8.81) 74.46 (8.81) 0.284
Urbanisation level 0.792
1 (most urbanised) 943 25.97 1816 25.01
2 871 23.99 1734 23.88
3 492 13.55 1024 14.10
4 492 13.55 1011 13.92
5 (least urbanised) 833 22.94 1677 23.09
Geographic region 0.454
 Northern 1876 51.67 3676 50.62
 Central 850 23.41 1688 23.24
 Southern 860 23.68 1789 24.64
 Eastern 45 1.24 109 1.50
Monthly income 0.385
 NT$0–15 840 2426 66.81 4826 66.46
 NT$15 841–25 000 932 25.67 1931 26.59
 ≥NT$25 001 273 7.52 505 6.95
Hypertension 2047 56.38 4099 56.44 0.946
Hyperlipidaemia 718 19.77 1308 18.01 0.026
Diabetes 792 21.81 1511 20.81 0.226
Coronary heart disease 838 23.08 1679 23.12 0.962
Inflammatory bowel disease 29 0.80 65 0.90 0.608
Gastrointestinal bleeding 122 3.36 265 3.65 0.442
Previous cancers 348 9.58 533 7.34 <0.001

The average exchange rate in 2015 was US$1.00 ≈ NT$30.

ADT, androgen deprivation therapy; NT, New Taiwan.